Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Boehringer Ingelheim
McKinsey
Dow
Colorcon

Last Updated: December 6, 2019

DrugPatentWatch Database Preview

DEPO-MEDROL Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Depo-medrol, and when can generic versions of Depo-medrol launch?

Depo-medrol is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in DEPO-MEDROL is methylprednisolone acetate. There are forty drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the methylprednisolone acetate profile page.

Drug patent expirations by year for DEPO-MEDROL
Drug Prices for DEPO-MEDROL

See drug prices for DEPO-MEDROL

Drug Sales Revenue Trends for DEPO-MEDROL

See drug sales revenues for DEPO-MEDROL

Recent Clinical Trials for DEPO-MEDROL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Indiana UniversityPhase 3
Amsterdam Rheumatology and Immunology CenterPhase 4
Tel-Aviv Sourasky Medical CenterPhase 4

See all DEPO-MEDROL clinical trials

Pharmacology for DEPO-MEDROL
Synonyms for DEPO-MEDROL
(6alpha,11beta)-11,17-dihydroxy-6-methyl-3,20-dioxopregna-1,4-dien-21-yl acetate
[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 21-acetate
200M356
21-Acetoxy-11|A,17-dihydroxy-6|A-methylpregna-1,4-diene-3,20-dione
43502P7F0P
53-36-1
54299-EP2308562A2
54299-EP2371811A2
6-METHYLPREDNISOLONE ACETATE
6.alpha.-Methylprednisolone 21-acetate
6.alpha.-Methylprednisolone acetate
6|A-Methyl Prednisolone 21-Acetate
6alpha-Methyl Prednisolone 21-Acetate
6alpha-Methylprednisolone 21-acetate
6alpha-Methylprednisolone acetate
A19446
AB00375925-05
AC1L1LBW
acetyl-methylprednisolone
AKOS015969745
AN-9611
BDBM233194
C-22293
C08179
CAS-53-36-1
CC-30908
CHEBI:6889
CHEMBL1364144
component of Neo-Medrol
CPD000718757
D-Med
D00979
depMedalone 40
depMedalone 80
Depo-Medrate
Depo-Medrin
Depo-medrol (TN)
Depo-Medrone
Depo-methylprednisolone
Depo-Methylprednisolone acetate
Depomedrone
Depometicort
Depot-Medrol
DSSTox_CID_3302
DSSTox_GSID_23302
DSSTox_RID_76966
DTXSID7023302
EINECS 200-171-3
HMS2233N14
HMS3259L07
Lemod Depo
LS-118505
M-Predrol
Medrol acetate
Medrol Enpak
Mepred
methyl prednisolone 21-acetate
Methyl prednisolone acetate
Methylprednisolon-21-acetat
Methylprednisolone 21-acetate
Methylprednisolone 21-acetate; Depo-medrate
Methylprednisolone acetate
Methylprednisolone acetate (JAN/USP)
Methylprednisolone acetate [USAN:JAN]
Methylprednisolone acetate [USP:JAN]
methylprednisolone-21-acetate
MLS001304003
MLS002667229
MolPort-002-528-604
NC00628
NCGC00159503-02
NSC 48985
NSC-48985
NSC48985
PLBHSZGDDKCEHR-LFYFAGGJSA-N
Pregna-1,20-dione, 11.beta.,17,21-trihydroxy-6.alpha.-methyl-, 21-acetate
Pregna-1,20-dione, 21-(acetyloxy)-11,17-dihydroxy-6-methyl-, (6.alpha.,11.beta.)-
Pregna-1,4-diene-3,20-dione, 11-beta,17,21-trihydroxy-6-alpha-methyl-, 21-acetate
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl-, 21-acetate
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl-, 21-acetate (8CI)
Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-11,17-dihydroxy-6-methyl-, (6-alpha,11-beta)-
Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-11,17-dihydroxy-6-methyl-, (6alpha,11beta)-
SAM002699893
SCHEMBL13231
SMR000718757
Solsolona
Solsolona [inj.]
Tox21_111722
U 8210
Ubrason
Ubrason [inj.]
Unidrol
UNII-43502P7F0P
Urbason crystal suspension
Vetacortyl
ZINC118912449

US Patents and Regulatory Information for DEPO-MEDROL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn DEPO-MEDROL methylprednisolone acetate INJECTABLE;INJECTION 011757-002 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn DEPO-MEDROL methylprednisolone acetate INJECTABLE;INJECTION 011757-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn DEPO-MEDROL methylprednisolone acetate INJECTABLE;INJECTION 011757-004 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Colorcon
Moodys
Dow
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.